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A B S T R A C T
The isoflavone, daidzein is a biologically active, plant-derived compound that interacts with estrogen receptors.
Data from previous studies have suggested that daidzein exerts beneficial effects in many diseases; however, as
an endocrine disrupter, it may also alter the functioning of the endocrine system. Data regarding the effect of
daidzein on the morphofunctional and histological parameters of the hypothalamic–pituitary–adrenal (HPA)
system is still lacking. Therefore, using the newCAST stereological software, we investigated the effects of
chronic (21 days) daidzein treatment on corticotropin-releasing hormone (CRH) neurons within the hypotha-
lamus and corticotropes (ACTH cells) in the pituitary, while image analysis was employed to-examine the in-
tensity of fluorescence of CRH in the median eminence (ME) and adrenocorticotropin hormone in the pituitary in
adult orchidectomized (Ovx) rats. Circulating ACTH and corticosterone levels were also analyzed. This study
showed that daidzein treatment decreased the volume density of CRH neurons within the paraventricular nu-
cleus as well as CRH immunofluorescence in the ME. The total number of ACTH cells was decreased, while ACTH
cell volume and the intensity of ACTH fluorescence were increased following daidzein treatment. Both ACTH
and corticosterone blood levels were increased after daidzein administration. The results of performed experi-
ments clearly demonstrate that volume density of CRH neurons; total number and volume of ACTH cells, as well
as stress hormones levels are vulnerable to the effects of daidzein.
1. Introduction
Activation of the hypothalamic–pituitary–adrenal (HPA) system is
considered to be a characteristic response to physical or psychological
stress, the purpose of which is to maintain equilibrium between or-
ganisms and their environment (de Kloet et al., 2005). Stress-related
inputs are integrated in the paraventricular nucleus (PVN) of the hy-
pothalamus to induce the secretion of corticotropin-releasing hormone
(CRH) and arginine vasopressin (AVP), which stimulate adrenocorti-
cotropic hormone (ACTH) secretion from the pituitary, subsequently
inducing glucocorticoids production by the adrenals. The HPA system
activation is terminated by a negative feedback action of glucocorti-
coids: elevated levels of glucocorticoids decrease the synthesis of AVP,
CRH and ACTH in a direct and indirect manner through the pituitary,
hypothalamus and hippocampus (Whitnall, 1993). The activity of the
HPA system shows pronounced sex-related differences (glucocorticoid
levels are thus higher in females than in males) and estradiol is believed
to play a causal modulatory role (Handa et al., 1994). Inter alia, es-
tradiol may directly enhance CRH gene transcription in the hypotha-
lamus via binding to estrogen-responsive elements on the CRH gene
(Vamvakopoulos and Chrousos, 1993).
Phytoestrogens are estrogens that present in some plant. They are
structurally and functionally similar to estrogens (Patisaul and
Jefferson, 2010). Daidzein, one of the major isoflavones in soybeans,
works by binding to estrogen receptors (ER) (Kuiper et al., 1998).
Previous studies have revealed that daidzein exerts beneficial effects
such as: improvement of preovulatory follicles development (Liu and
Zhang, 2008), anti-cancer (Messina et al., 1994) and neuroprotective
effects (Zhang et al., 2002), has antioxidative properties (Dwiecki et al.,
2009), and that it effects could be dose-dependant (Benassayag et al.,
2002). On the contrary, in view of estrogen’s essential role in growth,
differentiation and homeostasis, isoflavones may be classified as en-
docrine disruptors since they alter the normal functioning of the en-
docrine system (Henley and Korach, 2010).
https://doi.org/10.1016/j.acthis.2017.12.006
Received 12 October 2017; Received in revised form 12 December 2017; Accepted 12 December 2017
⁎ Corresponding author at: Department of Cytology, Institute for Biological Research “Siniša Stanković”, 142, despot Stefan, Blvd., 11060 Belgrade, Serbia.
E-mail address: lanat@ibiss.bg.ac.rs (S. Trifunović).
Acta Histochemica xxx (xxxx) xxx–xxx
0065-1281/ © 2017 Elsevier GmbH. All rights reserved.
Please cite this article as: Trifunović, S., Acta Histochemica (2017), https://doi.org/10.1016/j.acthis.2017.12.006
And yet, few experiments have been conducted to assess the daid-
zein effects on the HPA system and, to our knowledge, none have ex-
amined the effects of daidzein on stereological parameters at the
hypothalamic–PVN and pituitary–ACTH levels by using the newCAST
stereological system in adult rats. This study was undertaken to provide
additional insight into the actions of daidzein by analyzing its effects on
the volume of PVN, volume density of CRH neurons, and the volume
density, volume and total number of ACTH cells in adult rats, con-
sidering the importance of the stereology approach as essential in the
discovery of new concepts in cell biology. In addition, the blood con-
centrations of ACTH and corticosterone were also determined.
2. Material and methods
All animal procedures complied with the EEC Directive (2010/63/
EU) on the protection of animals used for experimental and other sci-
entific purposes, and were approved by the Ethical Committee for the
Use of Laboratory Animals of the Institute for Biological Research,
‘Sinisa Stankovi’ University of Belgrade, Serbia.
The experiments were performed on adult, 2-month-old male Wistar
rats, kept in the facilities of the Institute for Biological Research “Siniša
Stanković”, Belgrade, Serbia. Under standard environmental conditions
(a 12 h light\dark cycle, 22 ± 2° C), the animals were kept in groups of
two per cage. Before entering the experiment, all the animals were fed
the standard chow diet for laboratory rats (Veterinary Institute
Subotica, Serbia). Two weeks prior to the start of the experiment the
rats were fed a soy-free diet prepared in cooperation with the
Department of Food, School of Veterinary Medicine, Belgrade, Serbia,
and INSHRA PKB, Belgrade, Serbia, according to Picherit et al. (2000).
Food and water were available ad libitum.
Under anesthesia (ketamine hydrochloride 15mg/kg b.w.), the an-
imals were orchidectomized (Orx) or sham-operated (So). Given that
sex steroids act on the whole HPA system, by orchidectomy we want to
minimize steroids influence and separate the effects of sex steroid and
daidzein. The first group of Orx rats was subcutaneously injected with
daidzein (D) (Nutraceutica) (30mg/kg b.w.) every day at 9 AM, for 3
weeks, two weeks after surgery. The applied dose of daidzein (30mg/kg
b.w.) was chosen to mimic human exposure to elevated concentrations
of isoflavones when nutritional supplements are used for therapeutic
purposes (Doerge and Sheehan, 2002). Daidzein was dissolved in a
minimal volume of absolute ethanol (0.1 ml) and then mixed with
sterile olive oil (0.2 ml). The So and the second Orx group received the
same volume of absolute ethanol in sterile olive oil and served as
controls. The injection strategy is equivalent to oral consummation in
terms of absorption rate (Jefferson et al., 2007) and provides an easy
control of the applied dose. All rats were euthanized by decapitation
under low ether anesthesia (ether ad narcosis Ph. Iug. III., Lek, Ljubl-
jana, Slovenia) 24 h after the last injection. The low ether anesthetic
provides relief from pain and tension (we used this anesthetic for
2min), and doesn’t affect ACTH and corticosterone hormone levels (de
Haan et al., 2002).
2.1. Tissue preparation
The hypothalamus and pituitary glands were excised, fixed in
Bouin's solution and dehydrated in increasing concentrations of ethanol
and xylene. After embedding in Histowax (Histolab Product AB,
Göteborg, Sweden), coronal serial sections of the hypothalamus (5 μm
thick) and a serial section of the pituitary (3 μm thick) were obtained
with a rotary microtome (RM 2125RT Leica, Glostrup, Denmark).
Sakura Tissue-Tek Accu-Edge Low-Profile microtome blades for ex-
tremely thin sectioning were used. We used cresyl violet acetate solu-
tion to identify nuclear structures within the hypothalamus.
2.2. Immunohistochemistry
Hypothalamic CRH-containing neurons in the PVN and CRH im-
munoreactivity in the median eminence (ME) were determined using
immunofluorescence. After dewaxing, hydration and rinsing in 0.01M
phosphate-buffered saline (PBS; pH 7.6 for 10min), the sections were
exposed to microwaves (700W) in 0.05M citrate-buffered (pH 6.0; for
2×10min) for antigen retrieval. Subsequently, the sections were wa-
shed in PBS (3×10min). To block nonspecific staining, the section
were preincubated in normal donkey serum (1:10) for 30min, and then
incubated overnight with rabbit anti-CRH (1:500 in PBS; ab8901-100
Abcam). After washing in PBS, the sections were incubated with donkey
anti-rabbit Alexa fluor 488 IgG (1:200; Invitrogen) for 2 h, then washed
in PBS and mounted in mowiol. Antibody specificity has been evaluated
by using blocking peptides (Trifunović et al., 2012) and the negative
control and the results ware complete loss of immunoreactivity within
PVN. Precisely, the specificity of CRH immunostaining was confirm by
co-incubation with 5-fold excess of blocking peptide, while the sections
were treated in the same way as described above: the antibody was
neutralized by incubation with the blocking peptide; the antibody that
was bound to the blocking peptide was no longer available to bind to
the epitope present in the protein (Fig. 1). The sections were examined
and photographed using a Zeiss Axiovert fluorescence microscope,
equipped with a camera and EC Plan-Apochromat.
Pituitary ACTH was localized using the peroxidase-antiperoxidase
method. Antiserum to rat ACTH (NIDDK-anti-r ACTH-IC; 1:200) was
obtained from Dr. A.F. Parlow, National Hormone Peptide Program,
Harbor-UCLA Medical Centre, Carson, CA, USA. The specificity of the
antisera was assessed by the National Institute of Diabetes and Digestive
and Kidney disease (NIDDK). Endogenous peroxidase activity was
blocked by incubation in a hydrogen peroxide solution in methanol.
After the blocking procedure and incubation with normal swine serum
(1:10; Dako, Glostrup, Denmark) for 1 h, the sections were overlaid
with the appropriate dilution of ACTH primary antibodies for 24 h at
room temperature. After washing in PBS, the sections were incubated
for another 1 h with the secondary antibody (polyclonal swine-anti-
rabbit; Dako, Glostrup, Denmark) and again rinsed with PBS. 0.05%
3,3-diaminobenzidine tetrachloride liquid substrate chromogen system
was used for antibody localization. Control sections were incubated
with rabbit non-immune serum at the same concentration as the pri-
mary antibody (in omission of the primary antibody). This resulted in
the complete loss of immunoreactivity in the pituitary gland sections
(Fig. 1).
Also, pituitary ACTH cells were determined using immuno-
fluorescence. After dewaxing, hydration and rinsing in PBS, the sections
were preincubated in normal donkey serum (1:10) for 30min and then
incubated in ACTH primary antibody for 24 h at room temperature.
After washing in PBS, the sections were incubated with donkey anti-
rabbit Alexa fluor 488 IgG (1:200; Invitrogen) for 2 h, then washed in
PBS and coverslipped with mowiol.
2.3. Image analysis
For the evaluation of CRH protein content within ME, measure-
ments of the relative intensity of fluorescent signal (RIF) were per-
formed with Image J, as described previously (Jensen, 2013). Using five
immunostained sections from different areas of ME (rostral, three
medial and caudal sections) for each animal the RIF for CRH within ME
were analyzed. The formula: RIF= Integrated Density – (selected CRH
positive area X Mean fluorescence of background readings) was used.
The sections were examined and photographed using a Zeiss Axiovert
fluorescence microscope, equipped with a camera and EC Plan-Apoc-
hromat. So, RIF for CRH content was measured in five sections per
animal, followed by calculating the average value per animals, and fi-
nally the average per group.
ACTH cell Image analysis: Images were obtained using a confocal
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laser scanning microscope Leica TCS SP5 II Basic (Leica Microsystems
CMS GmbH; Germany). An Ar-ion 488 nm laser was used for excitation
of green fluorescence. Imaging was done with a 40× or 63× objec-
tives. Analysis of confocal microscopy images was performed using the
Quantify option in LAS AF Lite software (Leica Microsystems CMS
GmbH; Germany). Relative intensity of fluorescence (RIF) was calcu-
lated according to Waters and Swedlow (2007). Intensity of fluores-
cence was measured on 100–150 ACTH cells per animal, in which the
nucleus was apparent.
2.4. Stereological measurements
Using a workstation controlled by a newCAST stereological software
package (VIS – Visiopharm Integrator System, Denmark) all stereo-
logical analyses were carried out.
The volume of PVN (every 10th section from each tissue block was
analyzed; interval between the section was 50 μm), pituitary volume
and volume density of ACTH cells (every 20th section from each tissue
block was analyzed; interval between the section was 60 μm) were es-
timated using Cavalieri’s principle, according to the method described
in detail by Trifunović et al. (2012).
The percentages of CRH neurons were obtained using photo-
micrographs of three fluorescently labeled sections from three levels
(rostral-bregma-1,6 mm; medial-bregma-1,8 mm; caudal-bregma-
2,0 mm; interval between the section approximately 0,2mm) of the
PVN for each animal. Photomicrographs for each animal were imported
into the VIS program. The percentages of immunolabeled CRH neurons
were calculated by counting the points hitting the CRH-ir neurons and
dividing the number with the number of points hitting the PVN area x
100.
A fractionator/physical dissector design with two levels of sampling
was used to estimate the total number of ACTH cells from all examined
groups according to the method described in detail (Manojlović-
Stojanoski et al., 2010). Sampling was systematically uniform from a
random start and the sampling distance between the first sections in
consecutive section pairs was 20 sections. Sections designated as sec-
tion pairs were firstly captured into a super image. One section in the
pair was designated the reference section and the other the ‘look up’
section. Then, the analysis was performed in both directions and this
doubles the first sampling fraction from 1/20th to 1/10th (sampling
fraction 1 (f1)= 1/10=0.1). We analyzed 1% of the selected tissue
and sampling fraction 2 for ACTH cell number was f2=0.01.
As the mean volume of a single ACTH cell is equivalent to the total
volume occupied by ACTH cells divided by their number, the size of a
single ACTH cell can be calculated (de Lima et al., 2007).
2.5. Blood ACTH, corticosterone and testosterone assays
Blood was collected from the trunk in two types of glass tubes
(anticoagulant-treated glass tubes, EDTA for ACTH analyses and tubes
without anticoagulant for corticosterone analyses). The samples were
stored at−70 °C until assayed for hormone concentrations in duplicate
within single assays. IMMULITE method (DPC, Los Angeles, USA) with
an intra-assay CV of 9.6%. was used for determination of ACTH
Fig. 1. Negative controls for: CRH and ACTH immune-
staining in the paraventricular nucleus and the pituitary
gland, respectively of adult rat. Photomicrographs a and b
represent negative controls for CRH and ACTH immune-
staining, photomicrographs b and d represent controls for
CRH and ACTH immune-staining. Scale bar=50 μm, white
arrows indicate CRH neurons within PVN (a, b); Scale
bar= 55 μm, black arrows indicate ACTH cells within pitui-
tary.
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concentration. The corticosterone concentration was determined by
immunoassay (R&D Systems Inc., Minneapolis, USA) with an intra-
assay CV of 8.0%. Serum testosterone concentrations were determined
without dilution, using a competitive immunoenzymatic colorimetric
method (EIAgen Testosterone Kit, Adaltis Italia S.p.A., Bologna, Italy),
in duplicate samples within a single assay, with an intra-assay CV of
6.2%.
2.6. Statistical analysis
All the results are expressed as means for six (stereological data) or
10 animals (hormonal level data) per group ± SD. Data were tested for
normality of distribution by the Kolmogorov–Smirnov test, whereas
homogeneity of variances was evaluated by Levene’s test. Duncan’s
multiple range test was used for post-hoc comparisons between the
groups. A confidence level of p < 0.05 was considered statistically
significant.
3. Results
3.1. Body mass and testosterone level
Data of the body mass and the testosterone level are presented in
Table 1. Body mass and the testosterone level were significantly
(p < 0.05) decreased after orchidectomy in comparison with So group.
The significant (p < 0.05) changes of body mass and testosterone level
in Orx+D group in relation to So and Orx rats, were observed.
3.2. Hypothalamus
The PVN was identified according to a rat brain atlas (Paxinos and
Watson, 2004). The main references used to locate the PVN were the
presence of the fornix and the 3rd ventricle. In adult rats, the PVN
begins at 1.5mm and extends to 2.1mm posterior to the bregma level.
The mean volumes of PVN were larger (p < 0.05) in the Orx
(0.19 ± 0.01mm3; or 55%) and Orx+D (0.17 ± 0.02mm3; or 42%)
compared to the So group (0.12 ± 0.01mm3) (Fig. 2B).
The majority of the CRH-immunopositive perikarya were located in
the medial parvicellular subdivision of the PVN, which is in accordance
with previous works (Kiss et al., 1991; Lennard et al., 1993; Simmons
and Swanson 2009). Histological analysis showed higher CRH-ir in the
Orx group compared to both So and Orx+D groups (Fig. 2A). The
percentage of CRH-ir in the Orx group (26.78 ± 2.1%) was higher
(p < 0.05) by 23% than in the So group (22.43 ± 2.3%), while the
same parameter in the Orx+D group (23.8 ± 1.3%) was reduced in
comparison to the Orx group (Fig. 2C).
CRH neurons with axons are projecting to hypophyseal portal ca-
pillaries in the external zone of the ME what is in accordance with
previous studies (Makara et al., 1979; Alonso et al., 1986; Aguilera and
Liu, 2012)
The stronger CRH staining intensity in the ME were detected in the
Orx group when compared to the So and Orx+D groups. The ImageJ
analysis showed higher (p < 0.05) relative intensity of fluorescence by
103% in the ME of the Orx group when compared to the So. Also, RIF in
ME of the Orx group showed higher values (p < 0.05) by 41% when
compared to the Orx+D groups. (Fig. 3)
3.3. Pituitary
The ACTH immunoreactive cells were irregularly shaped and lo-
cated alone or in groups between the capillaries in the pituitary pars
distalis, in all experimental rats. Histological analysis revealed more or
less the same number of ACTH cells in all experimental groups. In the
Orx+D group the volume of ACTH cells was greater in comparison to
the other two control groups (Fig. 4A).
The significant decrease (p < 0.05; 15%) of ACTH cells fluorescent
intensity were detected in the Orx group compared to the So group.
Following daidzein treatment, the same parameter increased by 46%
and 72% in comparison to the So and Orx groups, respectively (Fig. 4B).
The volume of pituitary and the volume density of ACTH cells in the
group Orx+D were not different from the respective values in the So
and Orx rats. The total number of ACTH cells was decreased (p < 0.05)
by 21% and 27% in the Orx+D group compared to the So and Orx rats,
respectively. The cell volume of ACTH cells was 27% and 34% greater
(p < 0.05) in the Orx+D group than in the So and Orx rats, respec-
tively (Fig. 5).
3.4. Hormonal analysis
The mean plasma ACTH concentration in the Orx+D group was
higher (p < 0.05) by 39% and 117% in comparison to the Orx and So
groups, respectively. Also, the same parameter was 56% higher
(p < 0.05) in the Orx group than in the So group (Fig. 6A). The mean
serum corticosterone concentration in the Orx+D group was higher
(p < 0.05) by 57% and 40% in comparison to the So and Orx groups,
respectively (Fig. 6B).
4. Discussion
There is growing public concern that exposure to phytoestrogens
may have deleterious effects on endocrine homeostasis. The purpose of
the present study was to determine whether exposure of adult rats to
the phytoestrogen daidzein influences histological, stereological and
biochemical parameters in the HPA system. In this study, we used the
orchidectomized rat as an appropriate model system for testing the
effects of hormone-like substances.
Substantial evidence suggests that reproductive steroids modulate
the response to stress. In our previous publication, we described in
detail the stimulatory activity of orchidectomy on stereological and
biochemical parameters at the hypothalamic and pituitary levels within
the HPA system (Trifunović et al., 2012).
Following daidzein treatment, the qualitative histological as well as
the stereological results showed decreased percentages of CRH neurons
and CRH content within the ME. Considering the ERs distribution in the
brain, more precisely in the parvocellular and magnocellular regions in
the PVN (Simerly et al., 1990), and the ability of daidzein to cross the
blood–brain barrier (Ma et al., 2010), a direct influence of daidzein
within the CNS is viable. The reduced number of CRH neurons obtained
in this study is opposed to the phytoestrogens-stimulated neurons
proliferation observed earlier (Pan et al., 2012), and the disagreement
could be explained (inter alia) by an indirect action of daidzein.
Moreover, our results have revealed increased circulating corticos-
terone levels following daidzein exposure. It is well known that glu-
cocorticoids serve a vital function in the negative feedback inhibition of
their own secretion, so fluctuations in the corticosterone level may
trigger changes at the hypothalamic level. Previous studies have in-
dicated that glucocorticoids bind their membrane receptors on PVN
neurons, eliciting an intracellular cascade that mobilizes the synthesis
of endocannabinoids which inhibit glutamate release, reducing the
neural activity of PVN neurons (Malcher-Lopes et al., 2003).
Table 1
XXX.
Group Body mass (g) Serum level of testosterone (ng/mL)
So 397.1 ± 26.1 1.570 ± 0.050
Orx 330.4 ± 32.3* 0.034 ± 0.010*
Orx+D 319 ± 27.8* 0.11 ± 0.009*,**
All values are the means ± SD, n= 8 animals per group.
* p < 0.05 vs. So.
** p < 0.05 vs. Orx.
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Furthermore, daidzein may have a direct effect on adrenals considering
the moderate to high ERα expression in the gland (Kuiper et al., 1997).
Also, lower levels of endogenous sex steroids, provoked by orchi-
dectomy, might potentiate daidzein-induced corticosterone secretion,
considering the competitive binding between the isoflavones and en-
dogenous sex steroids (Tham, 2002). Earlier studies have revealed an
increase (Hartley et al., 2003) or decrease (Caceres et al., 2014) in
corticosterone secretion following daidzein exposure, and variances
may be due to different animal ages and/or different experimental
approaches. It seems logical to assume, considering the results from this
study (the reduction of CRH activity), that at the hypothalamic level
dominates the indirect influence of daidzein by the glucocorticoid ne-
gative feedback.
Daidzein treatment provoked a decrease in ACTH cell number, and
increases in ACTH cell volume, intensity of ACTH fluorescence and
ACTH circulating level. Daidzein may act on the pituitary directly,
considering the ER distribution in all anterior and intermediate lobe cell
types (Mitchner et al., 1998), or over the hypothalamus and adrenal. It
seems, however, that lactotrophs (LH cell) are the major target for es-
trogen-like substances within the pituitary due to their abundance
(40%) (Chen, 1987) and the high ER expression within LH cells
(Mitchner et al., 1998) and reduced number of ACTH cells might be the
result of pituitary plasticity, namely to poly-hormonal corticotropes
(Childs, 1991). Also, the reduced CRH neuron activity might potentate
the decrease of number of ACTH cells. On the other hand the direct
action of daidzein, through ERs, could be cause for the increased pro-
duction of ACTH (increased ACTH content and circulating ACTH hor-
mone level). Apparently, ACTH cells represent the medium of complex,
both direct and indirect, action of daidzein with the increase of ACTH
levels as a resulting effect.
In summary, quantitative results from our stereological analysis plus
biochemical data indicate that effects of daidzein are different at the
level of the hypothalamus, pituitary and adrenals (under this experi-
mental condition). Separately observing, each of these organs contain
Fig. 2. CRH immuno-fluorescent stained neurons in the paraventricular nucleus-PVN (A); Volume of the PVN (B); percentage of CRH immunoreactive neurons (C) of sham-operated (So),
orchidectomized (Orx) orchidectomized and daidzein treated (Orx+D) adult rats. Scale bar= 50 μm, white arrows indicate CRH neurons within PVN. The values are means ± standard
deviation, n= 6 animals per group; a p < 0.05 vs. So, b p < 0.05 vs.
Fig. 3. CRH immunoreactivity and the relative intensity of CRH fluorescence in the median eminence in sham-operated (So), orchidectomized (Orx), orchidectomized and daidzein
treated (Orx+D) adult rats; 3V- third ventricle; white arrows indicate CRH protein content within ME; scale bar 50 μm. The values are means ± standard deviation, n=6 animals per
group; a p < 0.05 vs. So, b p < 0.05 vs. Orx.
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the ER and could be the direct target for daidzein. On the other hand,
keeping in mind that it is an in vivo study, these organs should be ob-
served within the totality of the HPA system with all the possible in-
teractions. Our findings suggest that the morphofunctional parameters
of stress system are sensitive to daidzein, in a view of: the increased
ACTH and corticosterone levels, the decreased CRH activity and
number of ACTH cell and increased ACTH cell activity. Accordingly, the
daidzein action on HPA system appears to be some complex summation
of direct influences and the indirect feedback mechanisms.
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Fig. 4. Immunoreactive corticotropes (ACTH cells; A) and the relative intensity of ACTH fluorescence (B) in the pituitary gland in sham-operated (So), orchidectomized (Orx) and
orchidectomized-daidzein treated (Orx+D) adult male rats. Scale bar 100 μm, insets scale bar 10 μm; the values are means ± standard deviation, n= 6 animals per group; a p < 0.05
vs. So, b p < 0.05 vs. Orx.
Fig. 5. Stereological parameters for pituitary corti-
cotropes in sham-operated (So), orchidectomized
(Orx), orchidectomized, orchidectomized and daid-
zein treated (Orx+D) adult rats: pituitary volume
(A); volume density of corticotropes (ACTH cells);
Total number of ACTH cells (C); Volume of ACTH
cells (D). The values are means ± standard devia-
tion, n=6 animals per group; a p < 0.05 vs. So, b
p < 0.05 vs. Orx.
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